RVMD
Revolution Medicines IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$30.64B
P/E Ratio
—
EPS
$-5.95
Beta
1.01
52W High
$155.70
52W Low
$34.00
50-Day MA
$110.87
200-Day MA
$75.83
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Revolution Medicines Inc
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Fundamentals
| Revenue (TTM) | 742,000 |
| Gross Profit (TTM) | $-987.33M |
| EBITDA | $-1.17B |
| Operating Margin | 0.00% |
| Return on Equity | -58.10% |
| Return on Assets | -30.10% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $8.28 |
| Price-to-Book | 18.32 |
| Price-to-Sales (TTM) | 9035.10 |
| EV/Revenue | 8370.02 |
| EV/EBITDA | -9.71 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -95.20% |
| Shares Outstanding | $212.59M |
| Float | $179.91M |
| % Insiders | 1.90% |
| % Institutions | 94.33% |
Historical Volatility
HV 10-Day
69.11%
HV 20-Day
135.76%
HV 30-Day
112.53%
HV 60-Day
82.03%
HV Rank
99.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($174.30 target)
4
Strong Buy17
BuyData last updated: 5/1/2026